TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Susumu Okano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.